Please enable JavaScript to continue using this application.

Compare $QTTB vs $UPB | Chartloom

Compare

$QTTB vs $UPB

Q32 Bio Inc · Upstream Bio Inc

QTTB

Q32 Bio Inc

UPB

Upstream Bio Inc

Compare $QTTB vs $UPB

Comparing Q32 Bio Inc and Upstream Bio Inc

QTTBQ32 Bio Inc

UPBUpstream Bio Inc

QTTBQ32 Bio Inc

Market cap

$248M

P/E (TTM)

8.22x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

142.4%

52W performance

178.9%

FCF yield

-8.0%

UPBUpstream Bio Inc

Market cap

$256M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

168.72x

Rev growth (TTM)

16.0%

YTD performance

-82.6%

52W performance

-75.2%

FCF yield

-53.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

QTTB

UPB

Detailed metrics comparison

QTTB

Q32 Bio Inc

UPB

Upstream Bio Inc

Market Cap

QTTB$248M

UPB$256M

Enterprise Value

QTTB$142M

UPB$176M

Price

QTTB$8.34

UPB$4.70

P/E Ratio

QTTB8.22x

UPBN/A

P/S Ratio

QTTB4.62x

UPB80.99x

EV/Sales

QTTB2.64x

UPB55.85x

EV/EBITDA

QTTB3.69x

UPB0.00x

P/B Ratio

QTTB2.31x

UPB1.02x

P/FCF Ratio

QTTBN/A

UPBN/A

EV/FCF

QTTB-7.16x

UPB-1.29x

PEG Ratio

QTTBN/A

UPBN/A

Forward P/E (NTM)

QTTBN/A

UPBN/A

Forward P/S (NTM)

QTTBN/A

UPB168.72x

Revenue (TTM)

QTTB$54M

UPB$3M

Revenue Growth (YoY)

QTTBN/A

UPB16.0%

Forward Rev Growth

QTTB215.1%

UPB-48.7%

Gross Margin (TTM)

QTTB0.0%

UPB0.0%

Operating Margin (TTM)

QTTB85.4%

UPB0.0%

EBITDA Margin (TTM)

QTTB71.6%

UPB-5376.3%

Net Margin (TTM)

QTTB93.7%

UPB-4955.7%

FCF Margin (TTM)

QTTB-36.9%

UPB-4321.2%

Net Income (TTM)

QTTB$50M

UPB$-157M

FCF (TTM)

QTTB$-20M

UPB$-136M

EPS (TTM)

QTTB$0.00

UPB-$2.87

ROE (TTM)

QTTB137.4%

UPB-4840.0%

ROA (TTM)

QTTB45.1%

UPB-4657.0%

ROIC (TTM)

QTTB111.6%

UPB-4840.0%

Cash

QTTB$106M

UPB$79M

Debt

QTTB$0

UPB$0

Net Cash/Debt

QTTB$106M

UPB$79M

Current Ratio (TTM)

QTTB20.30x

UPB27.99x

Quick Ratio (TTM)

QTTB19.80x

UPB27.84x

Debt/Equity (TTM)

QTTB2.29x

UPB0.00x

Debt/Assets (TTM)

QTTB0.0%

UPB0.0%

Interest Coverage (TTM)

QTTBN/A

UPBN/A

Net Debt/EBITDA (TTM)

QTTB0.00x

UPB0.00x

Beta

QTTB0.50

UPB2.30

52W Performance

QTTB178.9%

UPB-75.2%

YTD Performance

QTTB142.4%

UPB-82.6%

% from 52W High

QTTB-64.6%

UPB-86.0%

% from 52W Low

QTTB337.8%

UPB7.7%

Asset Turnover (TTM)

QTTB0.87x

UPB0.01x

FCF Yield (TTM)

QTTB-8.0%

UPB-53.4%

Earnings Yield (TTM)

QTTB20.3%

UPB-61.2%

Dividend Yield (TTM)

QTTBN/A

UPBN/A

Rule of 40

QTTB-36.9

UPB-4,305.2

EV/GP/RG

QTTBN/A

UPBN/A

Ticker research

View QTTB research View UPB research

Metric	QTTB Q32 Bio Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$248M	$256M
Enterprise Value	$142M	$176M
Price	$8.34	$4.70
P/E Ratio	8.22x	N/A
P/S Ratio	4.62x	80.99x
EV/Sales	2.64x	55.85x
EV/EBITDA	3.69x	0.00x
P/B Ratio	2.31x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.16x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	168.72x
Revenue & Growth
Revenue (TTM)	$54M	$3M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	215.1%	-48.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	85.4%	0.0%
EBITDA Margin (TTM)	71.6%	-5376.3%
Net Margin (TTM)	93.7%	-4955.7%
FCF Margin (TTM)	-36.9%	-4321.2%
Net Income (TTM)	$50M	$-157M
FCF (TTM)	$-20M	$-136M
EPS (TTM)	$0.00	-$2.87
ROE (TTM)	137.4%	-4840.0%
ROA (TTM)	45.1%	-4657.0%
ROIC (TTM)	111.6%	-4840.0%
Financial Health
Cash	$106M	$79M
Debt	$0	$0
Net Cash/Debt	$106M	$79M
Current Ratio (TTM)	20.30x	27.99x
Quick Ratio (TTM)	19.80x	27.84x
Debt/Equity (TTM)	2.29x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	2.30
52W Performance	178.9%	-75.2%
YTD Performance	142.4%	-82.6%
% from 52W High	-64.6%	-86.0%
% from 52W Low	337.8%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.01x
FCF Yield (TTM)	-8.0%	-53.4%
Earnings Yield (TTM)	20.3%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36.9	-4,305.2
EV/GP/RG	N/A	N/A
Ticker research	View QTTB research	View UPB research

Valuation

P/E Ratio

QTTB

8.22x

P/S Ratio

QTTB

4.62x

UPB

80.99x

EV/FCF

QTTB

-7.16x

UPB

-1.29x

Growth & revenue

Revenue Growth TTM

UPB

16.0%

Forward Revenue Growth

QTTB

215.1%

UPB

-48.7%

Profitability & performance

Gross Margin

QTTB

0.0%

UPB

0.0%

ROE

QTTB

137.4%

UPB

-4840.0%

FCF Yield %

QTTB

-8.0%

UPB

-53.4%

52-Week Performance

QTTB

178.9%

UPB

-75.2%

Detailed metrics comparison

QTTB

Q32 Bio Inc

UPB

Upstream Bio Inc

Market Cap

QTTB$248M

UPB$256M

Enterprise Value

QTTB$142M

UPB$176M

Price

QTTB$8.34

UPB$4.70

P/E Ratio

QTTB8.22x

UPBN/A

P/S Ratio

QTTB4.62x

UPB80.99x

EV/Sales

QTTB2.64x

UPB55.85x

EV/EBITDA

QTTB3.69x

UPB0.00x

P/B Ratio

QTTB2.31x

UPB1.02x

P/FCF Ratio

QTTBN/A

UPBN/A

EV/FCF

QTTB-7.16x

UPB-1.29x

PEG Ratio

QTTBN/A

UPBN/A

Forward P/E (NTM)

QTTBN/A

UPBN/A

Forward P/S (NTM)

QTTBN/A

UPB168.72x

Revenue (TTM)

QTTB$54M

UPB$3M

Revenue Growth (YoY)

QTTBN/A

UPB16.0%

Forward Rev Growth

QTTB215.1%

UPB-48.7%

Gross Margin (TTM)

QTTB0.0%

UPB0.0%

Operating Margin (TTM)

QTTB85.4%

UPB0.0%

EBITDA Margin (TTM)

QTTB71.6%

UPB-5376.3%

Net Margin (TTM)

QTTB93.7%

UPB-4955.7%

FCF Margin (TTM)

QTTB-36.9%

UPB-4321.2%

Net Income (TTM)

QTTB$50M

UPB$-157M

FCF (TTM)

QTTB$-20M

UPB$-136M

EPS (TTM)

QTTB$0.00

UPB-$2.87

ROE (TTM)

QTTB137.4%

UPB-4840.0%

ROA (TTM)

QTTB45.1%

UPB-4657.0%

ROIC (TTM)

QTTB111.6%

UPB-4840.0%

Cash

QTTB$106M

UPB$79M

Debt

QTTB$0

UPB$0

Net Cash/Debt

QTTB$106M

UPB$79M

Current Ratio (TTM)

QTTB20.30x

UPB27.99x

Quick Ratio (TTM)

QTTB19.80x

UPB27.84x

Debt/Equity (TTM)

QTTB2.29x

UPB0.00x

Debt/Assets (TTM)

QTTB0.0%

UPB0.0%

Interest Coverage (TTM)

QTTBN/A

UPBN/A

Net Debt/EBITDA (TTM)

QTTB0.00x

UPB0.00x

Beta

QTTB0.50

UPB2.30

52W Performance

QTTB178.9%

UPB-75.2%

YTD Performance

QTTB142.4%

UPB-82.6%

% from 52W High

QTTB-64.6%

UPB-86.0%

% from 52W Low

QTTB337.8%

UPB7.7%

Asset Turnover (TTM)

QTTB0.87x

UPB0.01x

FCF Yield (TTM)

QTTB-8.0%

UPB-53.4%

Earnings Yield (TTM)

QTTB20.3%

UPB-61.2%

Dividend Yield (TTM)

QTTBN/A

UPBN/A

Rule of 40

QTTB-36.9

UPB-4,305.2

EV/GP/RG

QTTBN/A

UPBN/A

Ticker research

View QTTB research View UPB research

Metric	QTTB Q32 Bio Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$248M	$256M
Enterprise Value	$142M	$176M
Price	$8.34	$4.70
P/E Ratio	8.22x	N/A
P/S Ratio	4.62x	80.99x
EV/Sales	2.64x	55.85x
EV/EBITDA	3.69x	0.00x
P/B Ratio	2.31x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.16x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	168.72x
Revenue & Growth
Revenue (TTM)	$54M	$3M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	215.1%	-48.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	85.4%	0.0%
EBITDA Margin (TTM)	71.6%	-5376.3%
Net Margin (TTM)	93.7%	-4955.7%
FCF Margin (TTM)	-36.9%	-4321.2%
Net Income (TTM)	$50M	$-157M
FCF (TTM)	$-20M	$-136M
EPS (TTM)	$0.00	-$2.87
ROE (TTM)	137.4%	-4840.0%
ROA (TTM)	45.1%	-4657.0%
ROIC (TTM)	111.6%	-4840.0%
Financial Health
Cash	$106M	$79M
Debt	$0	$0
Net Cash/Debt	$106M	$79M
Current Ratio (TTM)	20.30x	27.99x
Quick Ratio (TTM)	19.80x	27.84x
Debt/Equity (TTM)	2.29x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	2.30
52W Performance	178.9%	-75.2%
YTD Performance	142.4%	-82.6%
% from 52W High	-64.6%	-86.0%
% from 52W Low	337.8%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.01x
FCF Yield (TTM)	-8.0%	-53.4%
Earnings Yield (TTM)	20.3%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36.9	-4,305.2
EV/GP/RG	N/A	N/A
Ticker research	View QTTB research	View UPB research